These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6158954)

  • 1. Transport rates of hepatic uptake and biliary excretion of an organic cation, acetyl procainamide ethobromide.
    Nakae H; Takada K; Asada S; Muranishi S
    Biochem Pharmacol; 1980 Oct; 29(19):2573-6. PubMed ID: 6158954
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acute renal failure on the disposition and elimination of [3H]N-acetyl procainamide ethobromide in the rat.
    Silberstein DJ; Bowmer CJ; Yates MS; Dean HG
    J Pharm Pharmacol; 1986 Sep; 38(9):679-85. PubMed ID: 2430089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study on saturated hepato-biliary transport of acetyl procainamide ethobromide.
    Nakae H; Muranishi S; Asada S; Takada K
    J Pharmacobiodyn; 1981 Aug; 4(8):584-9. PubMed ID: 6170747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choleresis and hepatic transport mechanisms. IV. Influence of bile salt choleresis on the hepatic transport of the organic cations, D-tubocurarine and N4 -acetyl procainamide ethobromide.
    Vonk RJ; Scholtens E; Keulemans GT; Meijer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Mar; 302(1):1-9. PubMed ID: 652045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of (3H)taurocholate on the biliary excretion of (14C)acetylprocaine amide ethobromide.
    Kuo SH; Johnson GE
    Can J Physiol Pharmacol; 1975 Oct; 53(5):888-94. PubMed ID: 1201494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical study of the hepato-biliary transport of drugs. V. Hepatic uptake and biliary excretion of organic cations.
    Nakae H; Sakata R; Muranishi S
    Chem Pharm Bull (Tokyo); 1976 May; 24(5):886-93. PubMed ID: 1021272
    [No Abstract]   [Full Text] [Related]  

  • 7. Excretion of procainamide into bile and saliva in rats with chronic renal failure.
    Basseches PJ; DiGregorio GJ
    Arch Int Pharmacodyn Ther; 1982 Jun; 257(2):180-7. PubMed ID: 6180690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic physical activity alters hepatobiliary excretory function in rats.
    Yiamouyiannis CA; Martin BJ; Watkins JB
    J Pharmacol Exp Ther; 1993 Apr; 265(1):321-7. PubMed ID: 8474015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic uptake and biliary excretion of N-acetyl procaine amide ethobromide in the rat.
    Hwang SW; Schanker LS
    Am J Physiol; 1973 Dec; 225(6):1437-43. PubMed ID: 4760457
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
    Kamath BL; Lai CM; Gupta SD; Durrani MJ; Yacobi A
    J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the hepatic uptake systems for organic cations with a photoaffinity probe of procainamide ethobromide.
    Mol WE; Müller M; Kurz G; Meijer DK
    Biochem Pharmacol; 1992 May; 43(10):2217-26. PubMed ID: 1599507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-life of N-acetylprocainamide in rats.
    Kamath BL; Yacobi A
    J Pharm Sci; 1980 Jul; 69(7):864-5. PubMed ID: 6156235
    [No Abstract]   [Full Text] [Related]  

  • 13. N-Acetyl-procainamide kinetics in the elderly.
    Galeazzi RL; Omar-Amberg C; Karlaganis G
    Clin Pharmacol Ther; 1981 Apr; 29(4):440-6. PubMed ID: 6162598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutical study of the hepato-biliary transport of drugs. VIII. Investigation of Hepatic uptake of organic cations by portal infusion.
    Nakae H; Iuchi Y; Muranishi S
    Chem Pharm Bull (Tokyo); 1978 Jan; 26(1):88-95. PubMed ID: 639168
    [No Abstract]   [Full Text] [Related]  

  • 15. Carrier-mediated transport of the organic cation procaine amide ethobromide by isolated rat liver parenchymal cells.
    Eaton DL; Klaassen CD
    J Pharmacol Exp Ther; 1978 Sep; 206(3):595-606. PubMed ID: 702324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in biliary excretory function by streptozotocin-induced diabetes.
    Watkins JB; Dykstra TP
    Drug Metab Dispos; 1987; 15(2):177-83. PubMed ID: 2882974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic transport of indocyanine green in rats chronically intoxicated with carbon tetrachloride.
    Iga T; Yokota M; Sugiyama Y; Awazu S; Hanano M
    Biochem Pharmacol; 1980 May; 29(9):1291-7. PubMed ID: 7397012
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue distribution of N-acetylprocainamide in rats.
    Yacobi A; Stampfli HF; Lai CM; Kamath BL
    Drug Metab Dispos; 1981; 9(3):193-5. PubMed ID: 6166443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition study of procainamide and N-acetylprocainamide during subacute administration in rats.
    Kamath BL; Lai CM; Krasula RW; Stampfli HF; Gupta SD; Yacobi A
    Toxicol Appl Pharmacol; 1982 Jan; 62(1):158-66. PubMed ID: 6175050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.